Follow the LIQUIDIA CORPORATION share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €6.1bn. The latest transaction was reported on 21 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Canaan VIII LP. Every trade is accessible without an account.
8
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate LIQUIDIA CORPORATION Buy (bullish), based on 8 analysts. Average price target: US$107.75.
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,029 of 29,064 companies
49.1
score / 100
Value
32
Quality
66
FCF yld-0.7%
Earn yld-1.1%
EV/EBITDA·
ROE132%
Gross mgn92%
Net mgn-44%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
200,000 shares@ US$65.000.20% mcap33.4% of flowcommonSEC144:0001969223-26-000642
8 of 8 declarations
Acerca de LIQUIDIA CORPORATION
Liquidia Corporation es una empresa centrada en el desarrollo de terapias innovadoras para el tratamiento de enfermedades respiratorias. Utiliza su plataforma tecnológica de nanopartículas para mejorar la administración de fármacos.